. Disciplina de Pneumologia, Departamento de Clínica Médica, Universidade Federal do Paraná, Curitiba (PR) Brasil.
. Departamento de Cardiopneumologia, Hospital de Clínicas, Universidade Federal do Paraná, Curitiba (PR) Brasil.
J Bras Pneumol. 2022 Jan 7;47(6):e20210254. doi: 10.36416/1806-3756/e20210254. eCollection 2022.
To evaluate the efficacy of a mindfulness-based treatment (MBT) for smoking cessation or reduction and compare it with that of cognitive behavioral therapy (CBT).
This was a single-center randomized controlled clinical trial including 113 patients divided into two groups: MBT (n = 54) and CBT (n = 59). The interventions comprised eight 90-min sessions. The primary outcome was smoking cessation at 16 weeks after program initiation. Secondary outcomes included reduction in the mean number of cigarettes smoked/day at 16 weeks after treatment initiation, as well as smoking cessation and reduction in the number of cigarettes smoked/day at the last program session. Participants had to attend ≥ 50% of the sessions to be included in the primary outcome analysis. An intention-to-treat analysis was also performed.
There was no difference between the groups regarding the primary outcome (30.4% in the MBT group vs. 31.6% in the CBT group, p = 0.68) or immediate abstinence rates (47.8% in the MBT group vs. 36.8% in the CBT group, p = 0.47). Both treatments were equally effective in reducing the number of cigarettes smoked/day at the last program session (a reduction of 93.33% [0-100%] in the MBT group and of 70% [33.3-100%] in the CBT group, p = 0.92) and at 16 weeks after program initiation (a reduction of 57.1% [0-100%] in the MBT group and of 70% [25-100%] in the CBT group, p = 0.49).
MBT appears to be as effective as CBT for smoking cessation or reduction and can be an option for the treatment of tobacco use disorders in Brazil (Brazilian Registry of Clinical Trials identifier: RBR-3w2scz [http://www.ensaiosclinicos.gov.br]).
评估基于正念的治疗(MBT)对戒烟或减少吸烟的疗效,并与认知行为疗法(CBT)进行比较。
这是一项单中心随机对照临床试验,共纳入 113 名患者,分为两组:MBT(n=54)和 CBT(n=59)。干预措施包括 8 个 90 分钟的疗程。主要结局是在方案启动后 16 周的戒烟率。次要结局包括治疗开始后 16 周内平均每天吸烟量的减少,以及最后一个疗程的戒烟和吸烟量减少。参与者必须参加≥50%的疗程才能纳入主要结局分析。还进行了意向治疗分析。
两组在主要结局(MBT 组为 30.4%,CBT 组为 31.6%,p=0.68)或即时戒烟率(MBT 组为 47.8%,CBT 组为 36.8%,p=0.47)方面无差异。两种治疗方法在最后一次疗程时减少吸烟量的效果相当(MBT 组减少 93.33%[0-100%],CBT 组减少 70%[33.3-100%],p=0.92),在方案启动后 16 周时也相当(MBT 组减少 57.1%[0-100%],CBT 组减少 70%[25-100%],p=0.49)。
MBT 似乎与 CBT 一样有效,可作为巴西治疗烟草使用障碍的一种选择(巴西临床试验注册标识:RBR-3w2scz [http://www.ensaiosclinicos.gov.br])。